ReP USP - Resultado da busca

Trabalho de evento-resumo periodico
Toxicity evaluation of docosahexaenoic acid nanoencapsulated with anti-PECAM-1 (2021)
Leão, Matheus de Castro; Pohlmann, Adriana Raffin ; Farsky, Sandra Helena Poliselli ; Broering, Milena Fronza; Castro, Inar Alves de ; Guterres, Sílvia Stanisçuaski
Fonte: Atherosclerosis. Nome do evento: Congress European Atherosclerosis Society/EAS. Unidade: FCF
Assuntos: ARTERIOSCLEROSE, MACRÓFAGOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEÃO, Matheus de Castro et al. Toxicity evaluation of docosahexaenoic acid nanoencapsulated with anti-PECAM-1. Atherosclerosis. Clare: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: https://pdf.sciencedirectassets.com/271064/1-s2.0-S0021915021X00147/1-s2.0-S0021915021004846/main.pdf? Acesso em: 30 set. 2024. , 2021
APA
Leão, M. de C., Pohlmann, A. R., Farsky, S. H. P., Broering, M. F., Castro, I. A. de, & Guterres, S. S. (2021). Toxicity evaluation of docosahexaenoic acid nanoencapsulated with anti-PECAM-1. Atherosclerosis. Clare: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Recuperado de https://pdf.sciencedirectassets.com/271064/1-s2.0-S0021915021X00147/1-s2.0-S0021915021004846/main.pdf?
NLM
Leão M de C, Pohlmann AR, Farsky SHP, Broering MF, Castro IA de, Guterres SS. Toxicity evaluation of docosahexaenoic acid nanoencapsulated with anti-PECAM-1 [Internet]. Atherosclerosis. 2021 ; 331 e73 res. P053.[citado 2024 set. 30 ] Available from: https://pdf.sciencedirectassets.com/271064/1-s2.0-S0021915021X00147/1-s2.0-S0021915021004846/main.pdf?
Vancouver
Leão M de C, Pohlmann AR, Farsky SHP, Broering MF, Castro IA de, Guterres SS. Toxicity evaluation of docosahexaenoic acid nanoencapsulated with anti-PECAM-1 [Internet]. Atherosclerosis. 2021 ; 331 e73 res. P053.[citado 2024 set. 30 ] Available from: https://pdf.sciencedirectassets.com/271064/1-s2.0-S0021915021X00147/1-s2.0-S0021915021004846/main.pdf?
Trabalho de evento-resumo periodico
Effect of supplementation with resveratrol on biomarkers associated with atherosclerosis in humans (2021)
Santana, Tamires Miranda ; Ogawa, Lucas Yuiiti; Rogero, Marcelo Macedo ; Barroso, Lucia Pereira; Castro, Inar Alves de
Fonte: Atherosclerosis. Nome do evento: Congress European Atherosclerosis Society/EAS. Unidades: FSP, IME, FCF
Assuntos: BIOMARCADORES, ESTRESSE OXIDATIVO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTANA, Tamires Miranda et al. Effect of supplementation with resveratrol on biomarkers associated with atherosclerosis in humans. Atherosclerosis. Clare: Faculdade de Saúde Pública, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.atherosclerosis.2021.06.768. Acesso em: 30 set. 2024. , 2021
APA
Santana, T. M., Ogawa, L. Y., Rogero, M. M., Barroso, L. P., & Castro, I. A. de. (2021). Effect of supplementation with resveratrol on biomarkers associated with atherosclerosis in humans. Atherosclerosis. Clare: Faculdade de Saúde Pública, Universidade de São Paulo. doi:10.1016/j.atherosclerosis.2021.06.768
NLM
Santana TM, Ogawa LY, Rogero MM, Barroso LP, Castro IA de. Effect of supplementation with resveratrol on biomarkers associated with atherosclerosis in humans [Internet]. Atherosclerosis. 2021 ; 331 e251 res. P609.[citado 2024 set. 30 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2021.06.768
Vancouver
Santana TM, Ogawa LY, Rogero MM, Barroso LP, Castro IA de. Effect of supplementation with resveratrol on biomarkers associated with atherosclerosis in humans [Internet]. Atherosclerosis. 2021 ; 331 e251 res. P609.[citado 2024 set. 30 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2021.06.768
Trabalho de evento-resumo periodico
Could oxidative stress biomarkers be applied to improve risk stratification of patients with cardiovascular disease? (2021)
Pimentel, Mariana Vieira de Mello Barros ; Barroso, Lucia Pereira; Castro, Inar Alves de
Fonte: Atherosclerosis. Nome do evento: Congress European Atherosclerosis Society/EAS. Unidades: IME, FCF
Assuntos: BIOMARCADORES, ESTRESSE OXIDATIVO, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PIMENTEL, Mariana Vieira de Mello Barros e BARROSO, Lucia Pereira e CASTRO, Inar Alves de. Could oxidative stress biomarkers be applied to improve risk stratification of patients with cardiovascular disease?. Atherosclerosis. Clare: Instituto de Matemática e Estatística, Universidade de São Paulo. Disponível em: https://www.atherosclerosis-journal.com/article/S0021-9150(21)00916-3/pdf. Acesso em: 30 set. 2024. , 2021
APA
Pimentel, M. V. de M. B., Barroso, L. P., & Castro, I. A. de. (2021). Could oxidative stress biomarkers be applied to improve risk stratification of patients with cardiovascular disease? Atherosclerosis. Clare: Instituto de Matemática e Estatística, Universidade de São Paulo. Recuperado de https://www.atherosclerosis-journal.com/article/S0021-9150(21)00916-3/pdf
NLM
Pimentel MV de MB, Barroso LP, Castro IA de. Could oxidative stress biomarkers be applied to improve risk stratification of patients with cardiovascular disease? [Internet]. Atherosclerosis. 2021 ; 331 e210 res. P485.[citado 2024 set. 30 ] Available from: https://www.atherosclerosis-journal.com/article/S0021-9150(21)00916-3/pdf
Vancouver
Pimentel MV de MB, Barroso LP, Castro IA de. Could oxidative stress biomarkers be applied to improve risk stratification of patients with cardiovascular disease? [Internet]. Atherosclerosis. 2021 ; 331 e210 res. P485.[citado 2024 set. 30 ] Available from: https://www.atherosclerosis-journal.com/article/S0021-9150(21)00916-3/pdf
Artigo de periodico
Diminished cholesterol efflux mediated by HDL and coronary artery disease in young male anabolic androgenic steroid users (2019)
Souza, Francis Ribeiro de; Santos, Marcelo Rodrigues dos; Porello, Rafael Armani; Fonseca, Guilherme Wesley Peixoto da; Sayegh, Ana Luiza Carrari; Lima, Thaís Pinheiro; Ferreira, Fabiana Dias; Oliveira, Tiago Franco de; Yonamine, Maurício ; Takayama, Liliam; Pereira, Rosa Maria Rodrigues; Negrão, Carlos Eduardo; Passarelli, Marisa; Rochitte, Carlos Eduardo; Alves, Maria Janieire de Nazaré Nunes
Fonte: Atherosclerosis. Unidades: FCF, FM, EEFE
Assuntos: COLESTEROL, DOENÇAS CARDIOVASCULARES, ESTEROIDES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Francis Ribeiro de et al. Diminished cholesterol efflux mediated by HDL and coronary artery disease in young male anabolic androgenic steroid users. Atherosclerosis, v. 283, p. 100-105, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2019.02.006. Acesso em: 30 set. 2024.
APA
Souza, F. R. de, Santos, M. R. dos, Porello, R. A., Fonseca, G. W. P. da, Sayegh, A. L. C., Lima, T. P., et al. (2019). Diminished cholesterol efflux mediated by HDL and coronary artery disease in young male anabolic androgenic steroid users. Atherosclerosis, 283, 100-105. doi:10.1016/j.atherosclerosis.2019.02.006
NLM
Souza FR de, Santos MR dos, Porello RA, Fonseca GWP da, Sayegh ALC, Lima TP, Ferreira FD, Oliveira TF de, Yonamine M, Takayama L, Pereira RMR, Negrão CE, Passarelli M, Rochitte CE, Alves MJ de NN. Diminished cholesterol efflux mediated by HDL and coronary artery disease in young male anabolic androgenic steroid users [Internet]. Atherosclerosis. 2019 ; 283 100-105.[citado 2024 set. 30 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2019.02.006
Vancouver
Souza FR de, Santos MR dos, Porello RA, Fonseca GWP da, Sayegh ALC, Lima TP, Ferreira FD, Oliveira TF de, Yonamine M, Takayama L, Pereira RMR, Negrão CE, Passarelli M, Rochitte CE, Alves MJ de NN. Diminished cholesterol efflux mediated by HDL and coronary artery disease in young male anabolic androgenic steroid users [Internet]. Atherosclerosis. 2019 ; 283 100-105.[citado 2024 set. 30 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2019.02.006
Trabalho de evento-resumo periodico
Lipid transfers to HDL are diminished in women with overt hypothyroidism after total thyroidectomy (2018)
Sigal, Gilbert Alexandre; Tavoni, Thauany Martins; Freitas, Fatima Rodrigues de; Silva, Bruna Miranda de Oliveira; Brandão, Lenine Garcia; Maranhão, Raul Cavalcante
Fonte: Atherosclerosis. Nome do evento: Congress of the European Atherosclerosis Society/EAS. Unidades: FM, FCF
Assuntos: LIPÍDEOS, HIPOTIREOIDISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SIGAL, Gilbert Alexandre et al. Lipid transfers to HDL are diminished in women with overt hypothyroidism after total thyroidectomy. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf. Acesso em: 30 set. 2024. , 2018
APA
Sigal, G. A., Tavoni, T. M., Freitas, F. R. de, Silva, B. M. de O., Brandão, L. G., & Maranhão, R. C. (2018). Lipid transfers to HDL are diminished in women with overt hypothyroidism after total thyroidectomy. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. Recuperado de https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf
NLM
Sigal GA, Tavoni TM, Freitas FR de, Silva BM de O, Brandão LG, Maranhão RC. Lipid transfers to HDL are diminished in women with overt hypothyroidism after total thyroidectomy [Internet]. Atherosclerosis. 2018 ; 275 e167 res. P2.5.217.[citado 2024 set. 30 ] Available from: https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf
Vancouver
Sigal GA, Tavoni TM, Freitas FR de, Silva BM de O, Brandão LG, Maranhão RC. Lipid transfers to HDL are diminished in women with overt hypothyroidism after total thyroidectomy [Internet]. Atherosclerosis. 2018 ; 275 e167 res. P2.5.217.[citado 2024 set. 30 ] Available from: https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf
Trabalho de evento-resumo periodico
Chylomicron metabolism is impaired in patients with obstructive sleep apnea: effects of treatment with continuous positive airway pressure (2018)
Drager, Luciano Ferreira; Tavoni, Thauany Martins; Silva, Vanessa Martins da; Santos, Raul Dias dos; Pedrosa, Rodrigo Pinto; Bortolotto, Luiz Aparecido; Vinagre, Carmen Guilherme Christiano de Matos; Polotsky, Vsevolod Y; Lorenzi Filho, Geraldo; Maranhão, Raul Cavalcante
Fonte: Atherosclerosis. Nome do evento: Congress of the European Atherosclerosis Society/EAS. Unidades: FM, FCF
Assuntos: APNEIA DO SONO, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DRAGER, Luciano Ferreira et al. Chylomicron metabolism is impaired in patients with obstructive sleep apnea: effects of treatment with continuous positive airway pressure. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf. Acesso em: 30 set. 2024. , 2018
APA
Drager, L. F., Tavoni, T. M., Silva, V. M. da, Santos, R. D. dos, Pedrosa, R. P., Bortolotto, L. A., et al. (2018). Chylomicron metabolism is impaired in patients with obstructive sleep apnea: effects of treatment with continuous positive airway pressure. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. Recuperado de https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf
NLM
Drager LF, Tavoni TM, Silva VM da, Santos RD dos, Pedrosa RP, Bortolotto LA, Vinagre CGC de M, Polotsky VY, Lorenzi Filho G, Maranhão RC. Chylomicron metabolism is impaired in patients with obstructive sleep apnea: effects of treatment with continuous positive airway pressure [Internet]. Atherosclerosis. 2018 ; 275 e157 res. P2.2.182.[citado 2024 set. 30 ] Available from: https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf
Vancouver
Drager LF, Tavoni TM, Silva VM da, Santos RD dos, Pedrosa RP, Bortolotto LA, Vinagre CGC de M, Polotsky VY, Lorenzi Filho G, Maranhão RC. Chylomicron metabolism is impaired in patients with obstructive sleep apnea: effects of treatment with continuous positive airway pressure [Internet]. Atherosclerosis. 2018 ; 275 e157 res. P2.2.182.[citado 2024 set. 30 ] Available from: https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf
Trabalho de evento-resumo periodico
Plasma clearance of chylomicron remnants is delayed in aged subjects: a study with artificial emulsions (2018)
Tavoni, Thauany Martins; Vinagre, Carmen Guilherme Christiano de Matos; Freitas, Fatima Rodrigues; Mesquita, Carlos Henrique de; Vinagre, Juliana Christiano de Matos; Mariani, A. C; Kalil Filho, Roberto; Maranhão, Raul Cavalcante
Fonte: Atherosclerosis. Nome do evento: Congress of the European Atherosclerosis Society/EAS. Unidades: FM, FCF
Assuntos: EMULSÕES (FORMAS FARMACÊUTICAS), DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TAVONI, Thauany Martins et al. Plasma clearance of chylomicron remnants is delayed in aged subjects: a study with artificial emulsions. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf. Acesso em: 30 set. 2024. , 2018
APA
Tavoni, T. M., Vinagre, C. G. C. de M., Freitas, F. R., Mesquita, C. H. de, Vinagre, J. C. de M., Mariani, A. C., et al. (2018). Plasma clearance of chylomicron remnants is delayed in aged subjects: a study with artificial emulsions. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. Recuperado de https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf
NLM
Tavoni TM, Vinagre CGC de M, Freitas FR, Mesquita CH de, Vinagre JC de M, Mariani AC, Kalil Filho R, Maranhão RC. Plasma clearance of chylomicron remnants is delayed in aged subjects: a study with artificial emulsions [Internet]. Atherosclerosis. 2018 ; 275 e157 res. P2.2.181.[citado 2024 set. 30 ] Available from: https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf
Vancouver
Tavoni TM, Vinagre CGC de M, Freitas FR, Mesquita CH de, Vinagre JC de M, Mariani AC, Kalil Filho R, Maranhão RC. Plasma clearance of chylomicron remnants is delayed in aged subjects: a study with artificial emulsions [Internet]. Atherosclerosis. 2018 ; 275 e157 res. P2.2.181.[citado 2024 set. 30 ] Available from: https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf
Trabalho de evento-resumo periodico
Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model (2018)
Meneghini, Bianca Correa; Tavares, Elaine Rufo; Guido, Maria Carolina; Tavoni, Thauany Martins; Kalil Filho, Roberto; Maranhão, Raul Cavalcante
Fonte: Atherosclerosis. Nome do evento: International Symposium on Atherosclerosis/ISA. Unidades: FM, FCF
Assuntos: NANOPARTÍCULAS, ARTERIOSCLEROSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MENEGHINI, Bianca Correa et al. Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://www.atherosclerosis-supplements.com/article/S1567-5688(18)30192-2/pdf. Acesso em: 30 set. 2024. , 2018
APA
Meneghini, B. C., Tavares, E. R., Guido, M. C., Tavoni, T. M., Kalil Filho, R., & Maranhão, R. C. (2018). Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. Recuperado de https://www.atherosclerosis-supplements.com/article/S1567-5688(18)30192-2/pdf
NLM
Meneghini BC, Tavares ER, Guido MC, Tavoni TM, Kalil Filho R, Maranhão RC. Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model [Internet]. Atherosclerosis. 2018 ; 32 112-113 res. P3.088.[citado 2024 set. 30 ] Available from: https://www.atherosclerosis-supplements.com/article/S1567-5688(18)30192-2/pdf
Vancouver
Meneghini BC, Tavares ER, Guido MC, Tavoni TM, Kalil Filho R, Maranhão RC. Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model [Internet]. Atherosclerosis. 2018 ; 32 112-113 res. P3.088.[citado 2024 set. 30 ] Available from: https://www.atherosclerosis-supplements.com/article/S1567-5688(18)30192-2/pdf
Trabalho de evento-resumo periodico
Plasma kinetics of chylomicron in patients with obstructive sleep apnea: effects of treatment with continuous positive airway pressure (2018)
Drager, Luciano Ferreira; Tavoni, Thauany Martins; Silva, Vanessa Martins da; Santos, Raul Dias dos; Pedrosa, Rodrigo Pinto; Bortolotto, Luiz Aparecido; Vinagre, Carmen Guilherme Christiano de Matos; Polotsky, Vsevolod Y; Lorenzi Filho, Geraldo; Maranhão, Raul Cavalcante
Fonte: Atherosclerosis. Nome do evento: International Symposium on Atherosclerosis/ISA. Unidades: FM, FCF
Assuntos: APNEIA DO SONO, ARTERIOSCLEROSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DRAGER, Luciano Ferreira et al. Plasma kinetics of chylomicron in patients with obstructive sleep apnea: effects of treatment with continuous positive airway pressure. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://www.atherosclerosis-supplements.com/article/S1567-5688(18)30192-2/pdf. Acesso em: 30 set. 2024. , 2018
APA
Drager, L. F., Tavoni, T. M., Silva, V. M. da, Santos, R. D. dos, Pedrosa, R. P., Bortolotto, L. A., et al. (2018). Plasma kinetics of chylomicron in patients with obstructive sleep apnea: effects of treatment with continuous positive airway pressure. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. Recuperado de https://www.atherosclerosis-supplements.com/article/S1567-5688(18)30192-2/pdf
NLM
Drager LF, Tavoni TM, Silva VM da, Santos RD dos, Pedrosa RP, Bortolotto LA, Vinagre CGC de M, Polotsky VY, Lorenzi Filho G, Maranhão RC. Plasma kinetics of chylomicron in patients with obstructive sleep apnea: effects of treatment with continuous positive airway pressure [Internet]. Atherosclerosis. 2018 ; 32 63-64 res. P1.099.[citado 2024 set. 30 ] Available from: https://www.atherosclerosis-supplements.com/article/S1567-5688(18)30192-2/pdf
Vancouver
Drager LF, Tavoni TM, Silva VM da, Santos RD dos, Pedrosa RP, Bortolotto LA, Vinagre CGC de M, Polotsky VY, Lorenzi Filho G, Maranhão RC. Plasma kinetics of chylomicron in patients with obstructive sleep apnea: effects of treatment with continuous positive airway pressure [Internet]. Atherosclerosis. 2018 ; 32 63-64 res. P1.099.[citado 2024 set. 30 ] Available from: https://www.atherosclerosis-supplements.com/article/S1567-5688(18)30192-2/pdf
Trabalho de evento-resumo periodico
Lipid core nanoparticle associated with docetaxel reduces inflammation and cell proliferation in an atherosclerosis rabbit model (2018)
Guido, Maria Carolina; Meneghini, Bianca Correa; Tavares, Elaine Rufo; Tavoni, Thauany Martins; Kalil Filho, Roberto; Maranhão, Raul Cavalcante
Fonte: Atherosclerosis. Nome do evento: Congress of the European Atherosclerosis Society/EAS. Unidades: FM, FCF
Assuntos: ARTERIOSCLEROSE, NANOPARTÍCULAS, INFLAMAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUIDO, Maria Carolina et al. Lipid core nanoparticle associated with docetaxel reduces inflammation and cell proliferation in an atherosclerosis rabbit model. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf. Acesso em: 30 set. 2024. , 2018
APA
Guido, M. C., Meneghini, B. C., Tavares, E. R., Tavoni, T. M., Kalil Filho, R., & Maranhão, R. C. (2018). Lipid core nanoparticle associated with docetaxel reduces inflammation and cell proliferation in an atherosclerosis rabbit model. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. Recuperado de https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf
NLM
Guido MC, Meneghini BC, Tavares ER, Tavoni TM, Kalil Filho R, Maranhão RC. Lipid core nanoparticle associated with docetaxel reduces inflammation and cell proliferation in an atherosclerosis rabbit model [Internet]. Atherosclerosis. 2018 ; 275 e49 res. SAG19.5.[citado 2024 set. 30 ] Available from: https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf
Vancouver
Guido MC, Meneghini BC, Tavares ER, Tavoni TM, Kalil Filho R, Maranhão RC. Lipid core nanoparticle associated with docetaxel reduces inflammation and cell proliferation in an atherosclerosis rabbit model [Internet]. Atherosclerosis. 2018 ; 275 e49 res. SAG19.5.[citado 2024 set. 30 ] Available from: https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf
Trabalho de evento-resumo periodico
Effects of treatment with methotrexate associated to lipid nanoparticles on diabetic cardiomyopathy in rats (2017)
Maranhão, Raul Cavalcante ; Marques, Alyne França; Guido, Maria Carolina; Tavares, Elaine Rufo; Bispo, Deborah Lima; Melo, Marcelo Dantas Tavares de; Salemi, Vera Maria Cury
Fonte: Atherosclerosis. Nome do evento: European Atherosclerosis Society Congress (EAS). Unidade: FCF
Assuntos: NANOPARTÍCULAS, RATOS, METOTREXATO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARANHÃO, Raul Cavalcante et al. Effects of treatment with methotrexate associated to lipid nanoparticles on diabetic cardiomyopathy in rats. Atherosclerosis. Clare: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 30 set. 2024. , 2017
APA
Maranhão, R. C., Marques, A. F., Guido, M. C., Tavares, E. R., Bispo, D. L., Melo, M. D. T. de, & Salemi, V. M. C. (2017). Effects of treatment with methotrexate associated to lipid nanoparticles on diabetic cardiomyopathy in rats. Atherosclerosis. Clare: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Maranhão RC, Marques AF, Guido MC, Tavares ER, Bispo DL, Melo MDT de, Salemi VMC. Effects of treatment with methotrexate associated to lipid nanoparticles on diabetic cardiomyopathy in rats. Atherosclerosis. 2017 ; 263 e48 res. SAG052.[citado 2024 set. 30 ]
Vancouver
Maranhão RC, Marques AF, Guido MC, Tavares ER, Bispo DL, Melo MDT de, Salemi VMC. Effects of treatment with methotrexate associated to lipid nanoparticles on diabetic cardiomyopathy in rats. Atherosclerosis. 2017 ; 263 e48 res. SAG052.[citado 2024 set. 30 ]
Trabalho de evento-resumo periodico
Plasma lipids and lipid transfer to HDL in long-term bedridden and in sedentary subjects (2017)
Maranhão, Raul Cavalcante ; Oliveira, Wilson Camargo; Tavoni, Thauany Martins; Freitas, Fatima Rodrigues; Silva, Bruna Miranda; Kalil Filho, Roberto
Fonte: Atherosclerosis. Nome do evento: European Atherosclerosis Society Congress (EAS). Unidades: FCF, FM
Assuntos: SEDENTARISMO, LIPÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARANHÃO, Raul Cavalcante et al. Plasma lipids and lipid transfer to HDL in long-term bedridden and in sedentary subjects. Atherosclerosis. Amsterdam: Elsevier. Disponível em: https://doi.org/10.1016/j.atherosclerosis.2017.06.704. Acesso em: 30 set. 2024. , 2017
APA
Maranhão, R. C., Oliveira, W. C., Tavoni, T. M., Freitas, F. R., Silva, B. M., & Kalil Filho, R. (2017). Plasma lipids and lipid transfer to HDL in long-term bedridden and in sedentary subjects. Atherosclerosis. Amsterdam: Elsevier. doi:10.1016/j.atherosclerosis.2017.06.704
NLM
Maranhão RC, Oliveira WC, Tavoni TM, Freitas FR, Silva BM, Kalil Filho R. Plasma lipids and lipid transfer to HDL in long-term bedridden and in sedentary subjects [Internet]. Atherosclerosis. 2017 ; 263 e216.[citado 2024 set. 30 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2017.06.704
Vancouver
Maranhão RC, Oliveira WC, Tavoni TM, Freitas FR, Silva BM, Kalil Filho R. Plasma lipids and lipid transfer to HDL in long-term bedridden and in sedentary subjects [Internet]. Atherosclerosis. 2017 ; 263 e216.[citado 2024 set. 30 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2017.06.704
Trabalho de evento-resumo periodico
Next generation sequencing in the diagnosis of familial hypercholesterolemia (2017)
Borges, Jessica Bassabi; Bastos, Gisele Medeiros; Afonso, Thais Kristini Almendros; Rodrigues, Elisângela da Silva; Thurow, Helena Strelow; Faludi, André Arpad; Gonçalves, Rodrigo Marques; Sousa, Amanda Guerra de Moraes Rego; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Fonte: Atherosclerosis. Nome do evento: European Atherosclerosis Society Congress (EAS). Unidade: FCF
Assuntos: HIPERCOLESTEROLEMIA, VARIAÇÃO GENÉTICA, RATOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORGES, Jessica Bassabi et al. Next generation sequencing in the diagnosis of familial hypercholesterolemia. Atherosclerosis. Clare: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 30 set. 2024. , 2017
APA
Borges, J. B., Bastos, G. M., Afonso, T. K. A., Rodrigues, E. da S., Thurow, H. S., Faludi, A. A., et al. (2017). Next generation sequencing in the diagnosis of familial hypercholesterolemia. Atherosclerosis. Clare: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Borges JB, Bastos GM, Afonso TKA, Rodrigues E da S, Thurow HS, Faludi AA, Gonçalves RM, Sousa AG de MR, Hirata RDC, Hirata MH. Next generation sequencing in the diagnosis of familial hypercholesterolemia. Atherosclerosis. 2017 ; 263 e282 res. PO558.[citado 2024 set. 30 ]
Vancouver
Borges JB, Bastos GM, Afonso TKA, Rodrigues E da S, Thurow HS, Faludi AA, Gonçalves RM, Sousa AG de MR, Hirata RDC, Hirata MH. Next generation sequencing in the diagnosis of familial hypercholesterolemia. Atherosclerosis. 2017 ; 263 e282 res. PO558.[citado 2024 set. 30 ]
Trabalho de evento-resumo periodico
Lipids transfer to HDL in patients with heart failure was diminished and is correlated with IL-6 and BNP levels (2017)
Martine, Ana Elisa Marabini; Carvalho, Priscila O; Curiati, Milena N. C; Miranda, Bruna O; Freitas, Fatima R; Kalil Filho, Roberto; Barretto, Antonio Carlos Pereira; Maranhão, Raul Cavalcante
Fonte: Atherosclerosis. Nome do evento: European Atherosclerosis Society Congress (EAS). Unidades: FCF, FM
Assuntos: INSUFICIÊNCIA CARDÍACA, LIPOPROTEÍNAS HDL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARTINE, Ana Elisa Marabini et al. Lipids transfer to HDL in patients with heart failure was diminished and is correlated with IL-6 and BNP levels. Atherosclerosis. Amsterdam: Elsevier. Disponível em: https://doi.org/10.1016/j.atherosclerosis.2017.06.243. Acesso em: 30 set. 2024. , 2017
APA
Martine, A. E. M., Carvalho, P. O., Curiati, M. N. C., Miranda, B. O., Freitas, F. R., Kalil Filho, R., et al. (2017). Lipids transfer to HDL in patients with heart failure was diminished and is correlated with IL-6 and BNP levels. Atherosclerosis. Amsterdam: Elsevier. doi:10.1016/j.atherosclerosis.2017.06.243
NLM
Martine AEM, Carvalho PO, Curiati MNC, Miranda BO, Freitas FR, Kalil Filho R, Barretto ACP, Maranhão RC. Lipids transfer to HDL in patients with heart failure was diminished and is correlated with IL-6 and BNP levels [Internet]. Atherosclerosis. 2017 ; 263 e073.[citado 2024 set. 30 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2017.06.243
Vancouver
Martine AEM, Carvalho PO, Curiati MNC, Miranda BO, Freitas FR, Kalil Filho R, Barretto ACP, Maranhão RC. Lipids transfer to HDL in patients with heart failure was diminished and is correlated with IL-6 and BNP levels [Internet]. Atherosclerosis. 2017 ; 263 e073.[citado 2024 set. 30 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2017.06.243
Trabalho de evento-resumo periodico
Differences in lipid transfers to HDL between patients with coronary arterial disease with or without type 2 diabetes mellitus (2017)
Maranhão, Raul Cavalcante ; Tavoni, Thauany Martins; Laverdy Neto, Oscar Giese; Sprandel, Marília da Costa Oliveira; Kalil Filho, Roberto; Hueb, Whady Armindo
Fonte: Atherosclerosis. Nome do evento: European Atherosclerosis Society Congress (EAS). Unidades: FCF, FM
Assuntos: DIABETES MELLITUS, DOENÇAS CARDIOVASCULARES, LIPÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARANHÃO, Raul Cavalcante et al. Differences in lipid transfers to HDL between patients with coronary arterial disease with or without type 2 diabetes mellitus. Atherosclerosis. Amsterdam: Elsevier. Disponível em: https://doi.org/10.1016/j.atherosclerosis.2017.06.706. Acesso em: 30 set. 2024. , 2017
APA
Maranhão, R. C., Tavoni, T. M., Laverdy Neto, O. G., Sprandel, M. da C. O., Kalil Filho, R., & Hueb, W. A. (2017). Differences in lipid transfers to HDL between patients with coronary arterial disease with or without type 2 diabetes mellitus. Atherosclerosis. Amsterdam: Elsevier. doi:10.1016/j.atherosclerosis.2017.06.706
NLM
Maranhão RC, Tavoni TM, Laverdy Neto OG, Sprandel M da CO, Kalil Filho R, Hueb WA. Differences in lipid transfers to HDL between patients with coronary arterial disease with or without type 2 diabetes mellitus [Internet]. Atherosclerosis. 2017 ; 263 e217.[citado 2024 set. 30 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2017.06.706
Vancouver
Maranhão RC, Tavoni TM, Laverdy Neto OG, Sprandel M da CO, Kalil Filho R, Hueb WA. Differences in lipid transfers to HDL between patients with coronary arterial disease with or without type 2 diabetes mellitus [Internet]. Atherosclerosis. 2017 ; 263 e217.[citado 2024 set. 30 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2017.06.706
Trabalho de evento-resumo periodico
Methotrexate carried in lipid core nanoparticles reduced the infarction size and improved left ventricle function following acute myocardium infarction induced in rats (2017)
Maranhão, Raul Cavalcante ; Guido, Maria Carolina; Marques, Alyne França; Tavares, Elaine Rufo; Bispo, Deborah Lima; Melo, Marcelo Dantas Tavares de; Lima, Aline Derísio; Nicolau, José Carlos; Salemi, Vera Maria; Kalil Filho, Roberto
Fonte: Atherosclerosis. Nome do evento: European Atherosclerosis Society Congress (EAS). Unidades: FCF, FM
Assuntos: INFARTO DO MIOCÁRDIO, NANOPARTÍCULAS, RATOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARANHÃO, Raul Cavalcante et al. Methotrexate carried in lipid core nanoparticles reduced the infarction size and improved left ventricle function following acute myocardium infarction induced in rats. Atherosclerosis. Amsterdam: Elsevier. Disponível em: https://doi.org/10.1016/j.atherosclerosis.2017.06.405. Acesso em: 30 set. 2024. , 2017
APA
Maranhão, R. C., Guido, M. C., Marques, A. F., Tavares, E. R., Bispo, D. L., Melo, M. D. T. de, et al. (2017). Methotrexate carried in lipid core nanoparticles reduced the infarction size and improved left ventricle function following acute myocardium infarction induced in rats. Atherosclerosis. Amsterdam: Elsevier. doi:10.1016/j.atherosclerosis.2017.06.405
NLM
Maranhão RC, Guido MC, Marques AF, Tavares ER, Bispo DL, Melo MDT de, Lima AD, Nicolau JC, Salemi VM, Kalil Filho R. Methotrexate carried in lipid core nanoparticles reduced the infarction size and improved left ventricle function following acute myocardium infarction induced in rats [Internet]. Atherosclerosis. 2017 ; 263 e126.[citado 2024 set. 30 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2017.06.405
Vancouver
Maranhão RC, Guido MC, Marques AF, Tavares ER, Bispo DL, Melo MDT de, Lima AD, Nicolau JC, Salemi VM, Kalil Filho R. Methotrexate carried in lipid core nanoparticles reduced the infarction size and improved left ventricle function following acute myocardium infarction induced in rats [Internet]. Atherosclerosis. 2017 ; 263 e126.[citado 2024 set. 30 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2017.06.405
Trabalho de evento-resumo periodico
Study of APOB mutations and familial hypercholesterolemia phenotypes (2016)
Borges, J. Bassani; Bastos, G. Medeiros; Afonso, T. K. Almendros; Rodrigues, E. da Silva; Thurow, Helena Strelow; Hirata, Thiago Dominguez Crespo; Faludi, André Arpad; Gonçalves, R. Mendes; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Fonte: Atherosclerosis. Nome do evento: European Atherosclerosis Society Congress. Unidade: FCF
Assuntos: DISLIPIDEMIAS, HIPERCOLESTEROLEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORGES, J. Bassani et al. Study of APOB mutations and familial hypercholesterolemia phenotypes. Atherosclerosis. Clare: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 30 set. 2024. , 2016
APA
Borges, J. B., Bastos, G. M., Afonso, T. K. A., Rodrigues, E. da S., Thurow, H. S., Hirata, T. D. C., et al. (2016). Study of APOB mutations and familial hypercholesterolemia phenotypes. Atherosclerosis. Clare: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Borges JB, Bastos GM, Afonso TKA, Rodrigues E da S, Thurow HS, Hirata TDC, Faludi AA, Gonçalves RM, Hirata RDC, Hirata MH. Study of APOB mutations and familial hypercholesterolemia phenotypes. Atherosclerosis. 2016 ; 252 e43 res. EAS16-0766.[citado 2024 set. 30 ]
Vancouver
Borges JB, Bastos GM, Afonso TKA, Rodrigues E da S, Thurow HS, Hirata TDC, Faludi AA, Gonçalves RM, Hirata RDC, Hirata MH. Study of APOB mutations and familial hypercholesterolemia phenotypes. Atherosclerosis. 2016 ; 252 e43 res. EAS16-0766.[citado 2024 set. 30 ]
Artigo de periodico
Favorable effects of ezetimibe alone or in association with simvastatin on the removal from plasma of chylomicrons in coronary heart disease subjects (2014)
Mangili, Otavio Celeste; Gagliardi, Ana C. Moron; Mangili, Leonardo Celeste; Mesquita, Carlos H.; Cesar, Luiz A. Machado; Tanaka, Akira; Schaefer, Ernst J.; Maranhão, Raul Cavalcante ; Santos, Raul D.
Fonte: Atherosclerosis. Unidades: FM, FCF
Assuntos: LIPOPROTEÍNAS (TERAPIA), DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MANGILI, Otavio Celeste et al. Favorable effects of ezetimibe alone or in association with simvastatin on the removal from plasma of chylomicrons in coronary heart disease subjects. Atherosclerosis, v. 233, n. 1, p. 319-325, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2013.12.008. Acesso em: 30 set. 2024.
APA
Mangili, O. C., Gagliardi, A. C. M., Mangili, L. C., Mesquita, C. H., Cesar, L. A. M., Tanaka, A., et al. (2014). Favorable effects of ezetimibe alone or in association with simvastatin on the removal from plasma of chylomicrons in coronary heart disease subjects. Atherosclerosis, 233( 1), 319-325. doi:10.1016/j.atherosclerosis.2013.12.008
NLM
Mangili OC, Gagliardi ACM, Mangili LC, Mesquita CH, Cesar LAM, Tanaka A, Schaefer EJ, Maranhão RC, Santos RD. Favorable effects of ezetimibe alone or in association with simvastatin on the removal from plasma of chylomicrons in coronary heart disease subjects [Internet]. Atherosclerosis. 2014 ; 233( 1): 319-325.[citado 2024 set. 30 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2013.12.008
Vancouver
Mangili OC, Gagliardi ACM, Mangili LC, Mesquita CH, Cesar LAM, Tanaka A, Schaefer EJ, Maranhão RC, Santos RD. Favorable effects of ezetimibe alone or in association with simvastatin on the removal from plasma of chylomicrons in coronary heart disease subjects [Internet]. Atherosclerosis. 2014 ; 233( 1): 319-325.[citado 2024 set. 30 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2013.12.008
Trabalho de evento-resumo periodico
Acute coronary syndrome and gene polymorphisms influence leukocyte MRNA expression of adhesion molecules and inflammatory proteins (2014)
Hirata, Mario Hiroyuki ; Cavichioli, Débora; Germano, Juliana de Freitas; Braga, Aécio Assunção; Cerda, Alvaro; Fajardo, Cristina Moreno ; Sampaio, M. F; Santos, E. B; Menuso, L; Sousa, A. G. M. R; Hirata, Rosario Dominguez Crespo
Fonte: Atherosclerosis. Nome do evento: European Atherosclerosis Society Congress (EAS). Unidade: FCF
Assuntos: POLIMORFISMO, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HIRATA, Mario Hiroyuki et al. Acute coronary syndrome and gene polymorphisms influence leukocyte MRNA expression of adhesion molecules and inflammatory proteins. Atherosclerosis. Clare: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 30 set. 2024. , 2014
APA
Hirata, M. H., Cavichioli, D., Germano, J. de F., Braga, A. A., Cerda, A., Fajardo, C. M., et al. (2014). Acute coronary syndrome and gene polymorphisms influence leukocyte MRNA expression of adhesion molecules and inflammatory proteins. Atherosclerosis. Clare: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Hirata MH, Cavichioli D, Germano J de F, Braga AA, Cerda A, Fajardo CM, Sampaio MF, Santos EB, Menuso L, Sousa AGMR, Hirata RDC. Acute coronary syndrome and gene polymorphisms influence leukocyte MRNA expression of adhesion molecules and inflammatory proteins. Atherosclerosis. 2014 ; 235( 2): e41 res. EAS-0819.[citado 2024 set. 30 ]
Vancouver
Hirata MH, Cavichioli D, Germano J de F, Braga AA, Cerda A, Fajardo CM, Sampaio MF, Santos EB, Menuso L, Sousa AGMR, Hirata RDC. Acute coronary syndrome and gene polymorphisms influence leukocyte MRNA expression of adhesion molecules and inflammatory proteins. Atherosclerosis. 2014 ; 235( 2): e41 res. EAS-0819.[citado 2024 set. 30 ]
Artigo de periodico
Favorable effects of ezetimibe alone or in association with simvastatin on the removal from plasma of chylomicrons in coronary heart disease subjects (2014)
Mangili, Otavio Celeste; Gagliardi, Ana Carolina Moron; Mangili, Leonardo Celeste; Mesquita, Carlos Henrique de; Cesar, Luiz Antonio Machado; Tanaka, Akira; Schaefer, Ernst J; Maranhão, Raul Cavalcante ; Santos, Raul Dias
Fonte: Atherosclerosis. Unidades: FM, FCF
Assuntos: EMULSÕES (FORMAS FARMACÊUTICAS), DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MANGILI, Otavio Celeste et al. Favorable effects of ezetimibe alone or in association with simvastatin on the removal from plasma of chylomicrons in coronary heart disease subjects. Atherosclerosis, v. 233, n. 1, p. 319-325, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2013.12.008. Acesso em: 30 set. 2024.
APA
Mangili, O. C., Gagliardi, A. C. M., Mangili, L. C., Mesquita, C. H. de, Cesar, L. A. M., Tanaka, A., et al. (2014). Favorable effects of ezetimibe alone or in association with simvastatin on the removal from plasma of chylomicrons in coronary heart disease subjects. Atherosclerosis, 233( 1), 319-325. doi:10.1016/j.atherosclerosis.2013.12.008
NLM
Mangili OC, Gagliardi ACM, Mangili LC, Mesquita CH de, Cesar LAM, Tanaka A, Schaefer EJ, Maranhão RC, Santos RD. Favorable effects of ezetimibe alone or in association with simvastatin on the removal from plasma of chylomicrons in coronary heart disease subjects [Internet]. Atherosclerosis. 2014 ; 233( 1): 319-325.[citado 2024 set. 30 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2013.12.008
Vancouver
Mangili OC, Gagliardi ACM, Mangili LC, Mesquita CH de, Cesar LAM, Tanaka A, Schaefer EJ, Maranhão RC, Santos RD. Favorable effects of ezetimibe alone or in association with simvastatin on the removal from plasma of chylomicrons in coronary heart disease subjects [Internet]. Atherosclerosis. 2014 ; 233( 1): 319-325.[citado 2024 set. 30 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2013.12.008

Unidades USP

ReP

Filtros

Unidades USP

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Nome do evento

Indexado em

Afiliação dos autores externos normalizada

Afiliação dos autores externos não normalizada